Company Name: |
Energy Chemical
|
Tel: |
021-58432009 400-005-6266 |
Email: |
marketing@energy-chemical.com |
Products Intro: |
Product Name:8-Bromoguanosine3’,5’-cyclicmonophosphoricacid CAS:31356-94-2 Purity:NULL Package:10mg;5mg Remarks:NULL
|
Company Name: |
Shanghai Universal Biotech Co.,Ltd
|
Tel: |
13774214275 |
Email: |
zhouzz@univ-bio.com |
Products Intro: |
Product Name:8-Bromo-cGMP Package:10mg Remarks: 見(jiàn)優(yōu)寧維官網(wǎng)
|
Company Name: |
Beijing Qinling Pharmaceutical Co., Ltd.
|
Tel: |
010-61241352 18901327973 |
Email: |
834537306@qq.com |
Products Intro: |
Product Name:8-bromo-cyclic guanosine 3':5'-monophosphate CAS:31356-94-2 Purity:95% Package:5g,25g,50g
|
|
| 8-BR-CGMP Basic information |
Product Name: | 8-BR-CGMP | Synonyms: | 8-BR-CGMP;8-BROMOGUANOSINE-3',5'-CYCLIC-MONOPHOSPHORIC ACID;8-BROMOGUANOSINE-3',5'-CYCLIC MONOPHOSPHATE;8-bromocyclic GMP;8-Bromoguanosine-3'',5''-cyclic monophosphoric acid sodium salt;8-Bromoguanosine 3',5'-phosphoric acid;2-amino-8-bromo-9-[(1S,6R,8R,9R)-3,9-dihydroxy-3-keto-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-3H-purin-6-one;2-amino-8-bromo-9-[(1S,6R,8R,9R)-3,9-dihydroxy-3-oxo-2,4,7-trioxa-3$l^{5}-phosphabicyclo[4.3.0]nonan-8-yl]-3H-purin-6-one | CAS: | 31356-94-2 | MF: | C10H11BrN5O7P | MW: | 424.1 | EINECS: | | Product Categories: | | Mol File: | 31356-94-2.mol |  |
| 8-BR-CGMP Chemical Properties |
density | 2.96±0.1 g/cm3(Predicted) | pka | 1.01±0.60(Predicted) |
| 8-BR-CGMP Usage And Synthesis |
Uses | 8-Bromoguanosine 3'', 5'' -cyclic monophosphoric acid | Definition | ChEBI: A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic GMP bearing an additional bromo substituent at position 8 on the guanine ring. A membrane permeable cGMP analogue that activates protein kinase G (PKG). It is 4.3-fold more potent than cGMP in activatin
PKG1alpha and promotes relaxation of tracheal and vascular smooth muscle tissue in vitro. |
| 8-BR-CGMP Preparation Products And Raw materials |
|